RecruitingNCT02073500

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

Prospective Observational Study of Peritoneal Surface Malignancies (PSM) - Characterization, Models and Treatment Strategies.


Sponsor

Oslo University Hospital

Enrollment

300 participants

Start Date

Sep 1, 2009

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to identify biomarkers of disease recurrence and prognosis to optimize patient selection for treatment with cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), and through animal models to explore different treatment strategies for peritoneal surface malignancies (PSM).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting tissue and fluid samples from patients with cancers that have spread to the lining of the abdomen (a condition called peritoneal surface malignancy) to better understand this type of cancer spread and develop new laboratory models that could lead to better treatments. **You may be eligible if...** - You have been diagnosed with a cancer that has spread to the peritoneum (the inner lining of the abdominal cavity), such as colorectal cancer, appendix cancer, ovarian cancer, or mesothelioma - You are scheduled for surgery or a procedure where abdominal tissue or fluid samples can be collected - You are willing to allow tissue and fluid samples to be used for research - You are at least 18 years old **You may NOT be eligible if...** - You are not scheduled for a procedure where samples can be safely obtained - You are unwilling to consent to sample collection for research purposes - Your overall health is too poor to safely undergo sample collection - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational study.

Analysis of metastatic tissue and blood specimens collected from patients with PSM undergoing CRS-HIPEC. CRS: Removal of all macroscopically detectable tumor. HIPEC: Instillation of heated chemotherapy in the abdominal cavity to remove residual cancer disease.


Locations(1)

The Norwegian Radium Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02073500


Related Trials